Cyclical changes in susceptibility of a myeloma tumor (LPC-1) to immune destruction. I. Changes in reactivity with cytotoxic T lymphocytes and anti-H-2(d) sera
- E. Celis,
- A. H. Hale,
- J. H. Russell,
- H. N. Eisen
- Massachusetts Institute of Technology
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewAbstract
<p>One of six transplantable ascites tumors of BALB/c mice was found to become periodically resistant to cytotoxic T lymphocytes (CTL). About 12 days after LPC-1, a myeloma tumor, was transplanted it became resistant to lysis by allogenic CTL (anti-H-2(d)) and by CTL directed to trinitrophenyl groups or minor histocompatibility antigens. Susceptibility to lysis by all of these CTL was regained within 2 to 4 days after transfer of the resistant cells to a fresh BALB/c host. These changes were recurrent: in each transplantation cycle the early LPC-1 cells were susceptible and the late cells were resistant to CTL. Analyses with antisera (B10 anti-B10.D2) showed that the serologically recognized products of the H-2(d) haplotype were reduced about 10-fold on the LPC-1 cells that were resistant to CTL.</p>
Publication Information
Output type
Scholary Output:
Contribution to journal
Article
Research
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 954-958 (5 pages)Journal (Volume, Issue Number)
Journal of Immunology (Volume 122, Issue 3)Publication milestones
- Published - 12/01/1979
Publication status
Published - 12/01/1979
ISSN
0022-1767Publication IDs
- Scopus: 0018773716
- PubMed: 312828
Access to documents
Publication metrics
Metrics
Fractional count
1
Fractional count
0.25
Fractional count
3
Fractional count
0.75
Fractional count
1
Fractional count
1
PlumX
Captures
3
Citation count
15
